Abstract
Hemodynamic instability often leads to hypoperfusion, which has a significant impact on outcome in both medical and surgical patients. Measures to detect and treat tissue hypoperfusion early by correcting the imbalance between oxygen delivery and consumption is of particular importance. There are several studies targeting different hemodynamic endpoints in order to investigate the effects of goal-directed therapy on outcome. A so-called multimodal concept putting several variables in context follows simple logic and may provide a broader picture. Furthermore, rather than treating population based “normal” values of certain indices, this concept can be translated into the individualized patient care to reach adequate oxygen supply and tissue oxygenation in order to avoid under, or over resuscitation, which are equally harmful. The purpose of this review is to give an overview of current data providing the basis of this a multimodal, individualized approach of hemodynamic monitoring and treatment.
Introduction
Development of multiorgan disorders is often the result of hypoperfusion, which severely affects outcome of medical and surgical patients alike and substantially increases the utilization of resources and costs (1). Therefore, the use of early and efficient therapeutic strategies able to detect tissue hypoperfusion and to treat the imbalance between oxygen consumption and delivery is of particular importance (2). Traditional endpoints such as heart rate, blood pressure, mental status, and urine output can be useful in the initial identification of inadequate perfusion, but are limited in their ability to identify ongoing, compensated shock (3). Therefore, more detailed assessment of global macrohemodynamic indices such as cardiac output (CO) and derived variables and measures of oxygen delivery and uptake, may be necessary to guide treatment (4, 5). Furthermore, after the optimization of these parameters, indicators of tissue perfusion should also be assessed to verify the effectiveness of therapy (6).
Physiological Issues
The primary goal of the cardiorespiratory system is to deliver adequate oxygen to the tissues to meet their metabolic requirements. The adequacy of tissue oxygenation is determined by the balance between the rate of oxygen transport to the tissues (oxygen delivery, DO2) and the rate at which the oxygen is used by the tissues (oxygen consumption, VO2) (7). The standard formulas to determine oxygen delivery and oxygen consumption is shown in Figure 1.
Figure 1
In the critically ill and in the perioperative period, there is often an imbalance between delivery and consumption. Oxygen delivery can be inadequate if arterial oxygen content (CaO2) and/or CO is reduced (8, 9). The circulation can compensate to some extent, and VO2 is usually independent in a wide range of DO2. However, beyond a critical point any further drop in DO2 will inevitably result in a decrease in VO2. In other words, after exhausting compensatory resources VO2 becomes dependent on DO2 and aerobic metabolism will have to be switched to anaerobic metabolism, leading to metabolic acidosis and oxygen debt (10).
The principle task of acute care is to avoid or correct oxygen debt by optimization of the oxygen supply and consumption. Furthermore, it is just as important to recognize that DO2 and tissue perfusion has normalized, therefore any further measures to increase DO2 may do harm by unnecessary over resuscitation.
There is also mounting evidence that conventional parameters such as blood pressure, central venous pressure, heart rate are poor indicators of cardiac index or oxygen delivery (11, 12), and there is also increasing evidence that, for example, in high-risk surgery perioperative care algorithms based on advanced hemodynamic monitoring are beneficial (13, 14).
Goal-Directed Concept in Hemodynamic Monitoring
The multimodal concept in hemodynamic monitoring can be translated into the individualized use of target endpoints for hemodynamic stabilization instead of treating “normal” values, and can help to reach adequate oxygen supply and tissue oxygenation in order to avoid under or over resuscitation, which are equally harmful. It is important to note, that so-called “normal” values may be true for a population, but may be false for an individual patient.
Cardiac output and DO2 as resuscitation endpoints
Several clinical investigations were performed on CO and derived variables based goals directed hemodynamic support in high-risk surgery. In two recent meta-analyses, it was found that cardiac index and DO2 guided treatment resulted in reduced mortality as compared to high-risk surgical patients receiving standard therapy (13, 14).
Stroke volume variation and pulse pressure variation as resuscitation endpoints
Recently, less invasive devices assessing CO by pulse contour analysis based on the radial artery pressure signal have been introduced. Although these devices show lower precision compared to the gold standards of thermodilution, there is some evidence that these methods can adequately show changes and trends in the hemodynamic status (15). As pulse pressure variation and stroke volume variation are well established indicators of fluid responsiveness, these devices seem to be simple and useful alternatives to invasive hemodynamic monitoring (16). Furthermore, in recent studies fluid therapy guided by SVV and PPV proved to be more accurate than static preload indicators-based approaches and has also been shown to improve patient outcome, by reducing postoperative complication rate significantly (17, 18). However, pulse pressure variation and stroke volume variation are limited to patients who receive controlled mechanical ventilation with normal sinus rhythm (19, 20).
Venous to arterial CO2 gap as therapeutic endpoint
Another easily obtainable blood flow related blood gas parameter is the central venous to arterial carbon dioxide gap (dCO2). Several authors have reported increased dCO2 in different low flow states (21–23). In oxygen debt caused anaerobic metabolism, hydrogen ions are generated in two ways: (1) hydrolysis of adenosine triphosphate to adenosine diphosphate and (2) increased production of lactic acid (24). Hydrogen ions are buffered by bicarbonate presented in the cells, and this process will generate CO2 production (25). While arterial PaCO2 is variable and dependent on pulmonary gas exchange, central venous PvCO2 is dependent on the capability of the flow (i.e., CO) to wash out carbon dioxide from the tissues. The Fick principle adapted to carbon dioxide demonstrates the inverse relationship between the CO and dCO2 (26). This postulate that increased dCO2 reflects decreased flow was confirmed in several critically ill conditions such as severe sepsis, heart failure, and severe hypovolemia (27, 28). Furthermore, adding the dCO2 to ScvO2 for identifying VO2/DO2 >30%, there was an improvement in specificity, positive predictive, and negative predictive values (29).
In cases like severe sepsis, when oxygen uptake is insufficient due to microcirculatory and/or mitochondrial defects, ScvO2 may be elevated (i.e., false negative). Previous studies have suggested that under such circumstances the increased value of dCO2 (>5 mmHg), may help the clinician in detecting inadequate DO2 to tissues, hence the complementary use of ScvO2 and dCO2 is recommended (30–32).
Measures of oxygen delivery and extraction
Perhaps the most commonly used methods to assess global VO2/DO2 are mixed venous oxygen saturation (SvO2) and its surrogate ScvO2. Central venous oxygen saturation is an easily obtained parameter via a central venous catheter already in situ in most critically ill patients and it is often used as a marker of the balance between oxygen delivery and consumption. Because of the different positions of the pulmonary artery and central venous catheters (entire body in the case of SvO2 versus brain and the upper part of the body in the case of ScvO2) there has been a considerable debate on the interpretation of ScvO2 values as compared to SvO2. Most of the studies that have analyzed the relationship between ScvO2 and SvO2 have shown that ScvO2 is on an average 5% higher than SvO2 and is considered as a reasonable surrogate marker in the clinical setting (33–35). However, recent clinical trials, mainly on septic patients, were unable to show satisfactory agreement between ScvO2 and SvO2. This could in part be explained by modifications of blood flow distribution and oxygen extraction by brain and splanchnic tissues (36). It seems that ScvO2 and SvO2 are not numerically equivalent but the changes usually occur in a parallel manner (37).
The main factors, which influence ScvO2, are hemoglobin, arterial oxygen saturation of hemoglobin, CO, and oxygen consumption. Theoretically if three of these factors are kept constant, the value of ScvO2 reflects the changes of the latter. There are multiple physiologic, pathologic, and therapeutic factors, which influence venous oxygen saturation, such as anemia, hypovolemia, contractility, bleeding, sedation, fever, pain, etc. (38).
One of the important features of venous saturation is that it can be pathologic both when it is high and when it is low. In a recent large cohort of septic patients in the emergency department, it was found that mortality was 40% in patients admitted with an ScvO2 <70% but in patients with an initial ScvO2 of >90%, it was almost as high 34%. The latter was probably due to impaired oxygen utilization (39). High ScvO2 values may thus represent an inability of the cells to extract oxygen or microcirculatory shunting in sepsis (40). Therefore, additional measures are necessary to help evaluating high ScvO2 values, such as for example lactate, central venous to arterial dCO2, and by applying advanced invasive hemodynamic monitoring.
Lactate, the end product on anaerobic metabolism, has been thoroughly investigated over the last decades in critical care. It has good prognostic value in several clinical scenarios such as trauma, sepsis, and high-risk surgical patients (41). Not just the absolute value, but its change over time (kinetics: determined by production and clearance) seems an even better marker of adequate resuscitation and outcome (42). A lactate decrease by 20% or more per 2 h in the initial resuscitation of critically ill patients resulted shorter length of stay in the intensive care unit and a lower mortality rate when adjusted to predefined risk factors (43). However, if lactate kinetics is assessed every 2–6 h, which can be regarded as far too long considering that acute resuscitation should be corrected as soon as possible, it seems that lactate kinetics rather than absolute values should be followed as resuscitation endpoints. In cases, when lactate production or elimination is impaired, the evaluation of lactate clearance is difficult to interpret. These pathological circumstances can be liver failure (44) or seizures (45).
PPV, dCO2, and stroke volume guided fluid resuscitation
In a recent animal experiment, we tested the effect of stroke volume guided hemorrhage and fluid resuscitation (46). After baseline measurements (Tbsl), animals were bled until stroke volume index dropped by 50%, then measurements were repeated (T0). Thereafter animals were resuscitated with lactated Ringer’s solution until baseline SVI values were reached, then final measurements were recorded (Tend). After bleeding, the SVI decreased by the planned 50% at T0 and returned to its initial value by Tend (Table 1). The CI also decreased after bleeding and reached a higher value by Tend as compared to Tbsl. Pulse contour analysis driven SVV and PPV increased from Tbsl to T0 and normalized by Tend. ScvO2 decreased from Tbsl to T0 and although increased by Tend, it remained lower, with a mean difference of 5% as compared to Tbsl.
Table 1
| Tbsl | T0 | Tend | |
|---|---|---|---|
| Stroke volume index (mL/m2) | 26.8 ± 4.7 | 13.4 ± 2.3* | 26.6 ± 4.1# |
| Cardiac index (L/min/m2) | 2.6 ± 0.4 | 1.8 ± 0.3* | 2.9 ± 0.5*,# |
| Stroke volume variation (%) | 13.6 ± 4.3 | 22.6 ± 5.6* | 12.2 ± 4.3# |
| Pulse pressure variation (%) | 13.0 ± 4.5 | 24.5 ± 7.6* | 13 ± 4.2# |
| Venous to arterial carbon dioxide gap (mmHg) | 5.3 ± 2 | 9.6 ± 2.3* | 5.1 ± 2.6# |
| Central venous oxygen saturation (%) | 78 ± 7 | 61 ± 5* | 73 ± 9*,# |
| Hemoglobin (g/dL) | 12.05 ± 1.37 | 11.22 ± 1.39* | 8.45 ± 1.1*,# |
Hemodynamic. and blood gas changes during stroke volume based fluid resuscitation.
Data are expressed as mean ± SD; *p < 0.05 significantly different from Tbsl; #p < 0.05 significantly different from T0.
T0, baseline measurements; T1, measurements following the hemorrhage; Tend, measurements after the resuscitation. Data are presented as mean ± SD, statistically significant difference was considered p < 0.05.
*Significantly different from T0.
#Significantly different from Tend.
In these experiments, ScvO2 and dCO2 correlated well with changes in stroke volume. If the hemodynamic instability is corrected, stroke volume, PPV, SVV, and dCO2 are in the physiological range, the low ScvO2 can indicate a low hemoglobin level due to low oxygen delivery. These data also confirm that more parameters should be taken into account during resuscitation.
Conclusion
Early and adequate hemodynamic stabilization of the critically ill has a significant effect on outcome. Rather than following certain numbers in protocols or algorithms, a multimodal approach, of assessing hemodynamic variables together with the balance between oxygen delivery and consumption, may help to get a detailed picture about the hemodynamic status of our patients and also gives a chance for individualized treatment. The latter means that the evidence, which proved beneficial for a population in clinical studies gives the frame what we fine tune for the patient’s individual needs reflected by changes in this complex picture of physiology. Despite that this multimodal approach follows simple logic, it has currently not been completely proven, which renders the need for further clinical trials.
Statements
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
ShoemakerWCAppelPLKramHB. Role of oxygen debt in the development of organ failure sepsis, and death in high-risk surgical patients. Chest (1992) 102:208–15.10.1378/chest.102.1.208
2
ShoemakerWCAppelPLKramHB. Tissue oxygen debt as determinant of lethal and nonlethal postoperative organ failure. Crit Care Med (1988) 16:1117–20.10.1097/00003246-198811000-00007
3
GoodrichC. Endpoints of resuscitation: what should we be monitoring?AACN Adv Crit Care (2006) 17(3):306–16.10.1097/01256961-200607000-00010
4
DonatiAPelaiaPPietropaoliPPreiserJC. Do use ScvO2 and O2ER as therapeutical goals. Minerva Anestesiol (2011) 77:483–4.
5
MarikPEDesaiH. Goal directed fluid therapy. Curr Pharm Des (2012) 18:6215–24.10.2174/138161212803832399
6
BenesJPradlRChyrtaI. Perioperative hemodynamic optimization: a way to individual goals. In: VincentJL, editor. Annual Update in Intensive Care and Emergency Medicine 2012. New York: Springer (2012). p. 357–67.
7
ValletBTavernierBLundN. Assessment of tissue oxygenation in the critically ill. Eur J Anaesthesiol (2000) 17:221–9.10.1097/00003643-200004000-00003
8
PernerA. Diagnosing hypovolemia in the critically ill. Crit Care Med (2009) 37:2674–5.10.1097/CCM.0b013e3181ad77d8
9
SakrYDuboisMJDe BackerDCreteurJVincentJL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med (2004) 32(9):1825–31.10.1097/01.CCM.0000138558.16257.3F
10
VincentJL. The relationship between oxygen demand, oxygen uptake, and oxygen supply. Intensive Care Med (1990) 16(Suppl 2):145–8.10.1007/BF01785244
11
MarikPEBaramMVahidB. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest (2008) 134:172–8.10.1378/chest.07-2331
12
OsmanDRidelCRayPMonnetXAnguelNRichardCet alCardiac filling pressures are not appropriate to predict hemodynamic response to volume challenge. Crit Care Med (2007) 35:64–8.10.1097/01.CCM.0000249851.94101.4F
13
KernJWShoemakerWC. Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med (2002) 30:1686–92.10.1097/00003246-200208000-00002
14
GurgelSTdo NascimentoPJr. Maintaining tissue perfusion in high-risk surgical patients: a systematic review of randomized clinical trials. Anesth Analg (2011) 112:1384–91.10.1213/ANE.0b013e3182055384
15
MichardFTeboulJL. Using heart-lung interactions to assess fluid responsiveness during mechanical ventilation. Crit Care (2000) 4(5):282–9.10.1186/cc710
16
MarikPECavallazziRVasuTHiraniA. Dynamic changes in arterial waveform derived variables and fluid responsiveness in mechanically ventilated patients: a systematic review of the literature. Crit Care Med (2009) 37:2642–7.10.1097/CCM.0b013e3181a590da
17
SalzwedelCPuigJCarstensABeinBMolnarZKissKet alPerioperative goal-directed hemodynamic therapy based on radial arterial pulse pressure variation and continuous cardiac index trending reduces postoperative complications after major abdominal surgery: a multi-center, prospective, randomized study. Crit Care (2013) 17:R191.10.1186/cc12885
18
LopesMROliveiraMAPereiraVOLemosIPAulerJOJrMichardF. Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: a pilot randomized controlled trial. Crit Care (2007) 11:R100.10.1186/cc6117
19
MichardFTeboulJL. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest (2002) 121:2000–8.10.1378/chest.121.6.2000
20
MonnetXOsmanDRidelCLamiaBRichardCTeboulJL. Predicting volume responsiveness by using the end-expiratory occlusion in mechanically ventilated intensive care unit patients. Crit Care Med (2009) 37:951–6.10.1097/CCM.0b013e3181968fe1
21
GrundlerWWeilMHRackowEC. Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation (1986) 74:1071–4.10.1161/01.CIR.74.5.1071
22
CuschieriJRiversEPDonninoMWKatiliusMJacobsenGNguyenHBet alCentral venous-arterial carbon dioxide difference as an indicator of cardiac index. Intensive Care Med (2005) 31:818–22.10.1007/s00134-005-2602-8
23
BenjaminEPaluchTABergerSRPremusGWuCIbertiTJ. Venous hypercarbia in canine hemorrhagic shock. Crit Care Med (1987) 15:516–8.10.1097/00003246-198705000-00013
24
WeilMH. Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med (1986) 315:1616–8.10.1056/NEJM198612183152519
25
ValletBTeboulJLCainSCurtisS. Venoarterial CO2 difference during regional ischemic or hypoxic hypoxia. J Appl Physiol (2000) 89:1317–21.
26
LamiaBMonnetXTeboulJL. Meaning of arterio-venous PCO2 difference in circulatory shock. Minerva Anestesiol (2006) 72:597–604.
27
MecherCERackowECAstizMEWeilMH. Venous hypercarbia associated with severe sepsis and systemic hypoperfusion. Crit Care Med (1990) 18:585–9.10.1097/00003246-199006000-00001
28
AdroguéHJRashadMNGorinABYacoubJMadiasNE. Assessing acid-base status in circulatory failure. Differences between arterial and central venous blood. N Engl J Med (1989) 320:1312–6.10.1056/NEJM198905183202004
29
KocsiSDemeterGErcesDNagyEKaszakiJMolnarZ. Central venous-to-arterial CO2 gap is a useful parameter in monitoring hypovolemia-caused altered oxygen balance: animal study. Crit Care Res Pract (2013) 2013:583598.10.1155/2013/583598
30
ValléeFValletBMatheOParraguetteJMariASilvaSet alCentral venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock?Intensive Care Med (2006) 34:2218–25.10.1007/s00134-008-1199-0
31
FutierERobinEJabaudonMGuerinRPetitABazinJEet alCentral venous O2 saturation and venous-to-arterial CO2 difference as complementary tools for goal-directed therapy during high-risk surgery. Crit Care (2010) 14:R193.10.1186/cc9310
32
ValletBLebuffeG. How to titrate vasopressors against fluid loading in septic shock. Adv Sepsis (2007) 6:34–40.
33
ChawlaLSZiaHGutierrezGKatzNMSeneffMGShahM. Lack of equivalence between central and mixed venous oxygen saturation. Chest (2004) 126:1891–6.10.1378/chest.126.6.1891
34
ReinhartKKuhnHJHartogCBredleDL. Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill. Intensive Care Med (2004) 30:1572–8.10.1007/s00134-004-2337-y
35
VarpulaMKarlssonSRuokonenEPettiläV. Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock. Intensive Care Med (2006) 32:1336–43.10.1007/s00134-006-0270-y
36
van BeestPAvan IngenJBoermaECHolmanNDGroenHKoopmansMet alNo agreement of mixed venous and central venous saturation in sepsis, independent of sepsis origin. Crit Care (2010) 2010(14):R219.10.1186/cc9348
37
RiversE. Mixed versus central venous oxygen saturation may be not numerically equal, but both are still clinically useful. Chest (2006) 129:507–8.10.1378/chest.129.3.507
38
van BeestPAWietaschGScheerenT. Clinical review: use of venous oxygen saturations as a goal – a yet unfinished puzzle. Crit Care (2011) 15:232.10.1186/cc10351
39
PopeJVJonesAEGaieskiDFArnoldRCTrzeciakSShapiroNIet alEMShockNet. Multicenter study of central venous oxygen saturation (ScvO2) as a predictor of mortality in patients with sepsis. Ann Emerg Med (2010) 55:40–6.10.1016/j.annemergmed.2009.08.014
40
InceCSinaasappelM. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med (1999) 27:1369–77.10.1097/00003246-199907000-00031
41
MeregalliAOliveiraRPFriedmanG. Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients. Crit Care (2004) 8:R60–5.10.1186/cc2527
42
NguyenHBRiversEPKnoblichBPJacobsenGMuzzinAResslerJAet alEarly lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med (2004) 32:1637–42.10.1097/01.CCM.0000132904.35713.A7
43
JansenTCvan BommelJSchoonderbeekFJSleeswijk VisserSJvan der KloosterJMLimaAPet alEarly lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med (2010) 182:752–61.10.1164/rccm.200912-1918OC
44
KruseJAZaidiSACarlsonRW. Significance of blood lactate levels in critically ill patients with liver disease. Am J Med (1987) 83:77–82.10.1016/0002-9343(87)90500-6
45
OrringerCEEustaceJCWunschCDGardnerLB. Natural history of lactic acidosis after grand-mal seizures. A model for the study of an anion-gap acidosis not associated with hyperkalemia. N Engl J Med (1977) 297:796.10.1056/NEJM197710132971502
46
NemethMTanczosKDemeterGErcesDKaszakiJMikorAet alCentral venous oxygen saturation and carbon dioxide-gap as resuscitation targets in a hemorrhagic shock. Acta Anaesthesiol Scand (2014).10.1111/aas.12312
Summary
Keywords
hemodynamic optimization, cardiac output, stroke volume, central venous oxygen saturation, venous to arterial carbon dioxide gap
Citation
Tánczos K, Németh M and Molnár Z (2014) The Multimodal Concept of Hemodynamic Stabilization. Front. Public Health 2:34. doi: 10.3389/fpubh.2014.00034
Received
29 January 2014
Accepted
01 April 2014
Published
30 April 2014
Volume
2 - 2014
Edited by
Evangelos Giamarellos-Bourboulis, University of Athens, Greece
Reviewed by
Linda Johansson, Karolinska Institutet, Sweden; Peter Pickkers, Radboud University Medical Centre, Netherlands; George Dimopoulos, University Hospital Attikon, Greece
Copyright
© 2014 Tánczos, Németh and Molnár.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zsolt Molnár, Department of Anaesthesiology and Intensive Therapy, University of Szeged, 6 Semmelweis Street, Szeged 6725, Hungary e-mail: zsoltmolna@gmail.com
This article was submitted to Infectious Diseases, a section of the journal Frontiers in Public Health.
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.